Medeon Biodesign, Inc. (TPEX:6499)
Taiwan · Delayed Price · Currency is TWD 94.50
-0.80 (-0.84%)
Dec 31, 2025, 1:30 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 8.72 billion as of December 31, 2025. Its market cap has increased by 121.04% in one year.
Market Cap
8.72B
Enterprise Value
7.98B
Revenue
381.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
94.50
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 8.72B, an increase of 51.09%. That is a compound annual growth rate of 3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 245.82B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |